Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Issue 1 (8th January 2020)
- Record Type:
- Journal Article
- Title:
- Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. Issue 1 (8th January 2020)
- Main Title:
- Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
- Authors:
- Lussier, Firoza Z.
Pascoal, Tharick A.
Chamoun, Mira
Therriault, Joseph
Tissot, Cécile
Savard, Mélissa
Kang, Min Su
Mathotaarachchi, Sulantha
Benedet, Andrea L.
Parsons, Marlee
Qureshi, Muhammad Naveed Iqbal
Thomas, Émilie M.
Shin, Monica
Dion, Laurie‐Anne
Massarweh, Gassan
Soucy, Jean‐Paul
Tsai, I‐Huang
Vitali, Paolo
Ismail, Zahinoor
Rosa‐Neto, Pedro
Gauthier, Serge - Abstract:
- Abstract: Introduction: Mild behavioral impairment (MBI) is characterized by the emergence of neuropsychiatric symptoms in elderly persons. Here, we examine the associations between MBI and Alzheimer's disease (AD) biomarkers in asymptomatic elderly individuals. Methods: Ninety‐six cognitively normal elderly individuals underwent MRI, [ 18 F]AZD4694 β‐amyloid‐PET, and [ 18 F]MK6240 tau‐PET. MBI was assessed using the MBI Checklist (MBI‐C). Pearson's correlations and voxel‐based regressions were used to evaluate the relationship between MBI‐C score and [ 18 F]AZD4694 retention, [ 18 F]MK6240 retention, and gray matter (GM) volume. Results: Pearson correlations revealed a positive relationship between MBI‐C score and global and striatal [ 18 F]AZD4694 standardized uptake value ratios (SUVRs). Voxel‐based regression analyses revealed a positive correlation between MBI‐C score and [ 18 F]AZD4694 retention. No significant correlations were found between MBI‐C score and [ 18 F]MK6240 retention or GM volume. Conclusion: We demonstrate for the first time a link between MBI and early AD pathology in a cognitively intact elderly population, supporting the use of the MBI‐C as a metric to enhance clinical trial enrolment.
- Is Part Of:
- Alzheimer's & dementia. Volume 16:Issue 1(2020)
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 16:Issue 1(2020)
- Issue Display:
- Volume 16, Issue 1 (2020)
- Year:
- 2020
- Volume:
- 16
- Issue:
- 1
- Issue Sort Value:
- 2020-0016-0001-0000
- Page Start:
- 192
- Page End:
- 199
- Publication Date:
- 2020-01-08
- Subjects:
- Alzheimer's disease -- amyloid -- mild behavioral impairment -- neurodegeneration -- neuropsychiatric symptoms -- tau
Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.12007 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13177.xml